Pharmac Expands Funded Cancer Medicines Access to Adolescents and Young Adults
Audio narration · Coming soon
Pharmac will extend access to funded cancer medicines starting 14 October for adolescents and young adults with paediatric-origin cancers who meet eligibility criteria. This decision comes as part of efforts to improve treatment availability for younger cancer patients. Dr. David Hughes, Pharmac's Chief Medical Officer, announced the expansion.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews